Latest filing published 22 Aug 2017 for Prometic Life Sciences Inc., €9,420.
This profile gathers the share dealings of Andrew Trevor Bishop in Prometic Life Sciences Inc. The record holds 6 filings, for trades running from 13 May 2015 to 18 August 2017.
Every open-market trade on record is a purchase: 4 purchases worth €46k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2017 alone, the filings show 2 purchases and no sales.
A typical purchase (the median) is worth €11k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 22 August 2017, reports an open-market purchase of €9,420 in Prometic Life Sciences Inc. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations